Poulvac Marek's CVI+HVT Bivalent Poultry Vaccine
بولفاك ماريكس سي في آي + إتش في تي لقاح ماريك ثنائي التكافؤ للدواجن
Poulvac Marek's CVI+HVT is a frozen, cell-associated bivalent live virus vaccine containing the Rispens CVI 988 strain (Serotype 1) and the FC-126 Herpesvirus of Turkeys strain (HVT, Serotype 3). Indicated for the vaccination of 18-to-19 day embryonated eggs in ovo or 1-day-old chicks subcutaneously to prevent Marek's disease.
Dosage Form
N/A
Product Type
Biological
Manufacturer
Package
Ampules of 1,000, 2,000, and 4,000 doses stored in liquid nitrogen containers
Dosages
No dosage information available.
Withdrawal Periods
| Species | Meat (days) | Milk (days) | Eggs (days) |
|---|---|---|---|
| 21 | 0 | 0 |
Indications
-
Active immunization of healthy embryonated eggs and one-day-old chickens to aid in the prevention of neural, visceral, and ocular forms of Marek's disease.
تحصين أجنة البيض وكتاكيت عمر يوم للوقاية من أورام وأعراض مرض ماريك العصبي والحشوي والعييني.
Contraindications
No contraindications information available.
Precautions
-
Liquid nitrogen hazard: wear protective face shield, gloves, and protective clothing during ampule retrieval.
خطر النيتروجين السائل: يجب ارتداء واقي الوجه والقفازات العازلة أثناء استخراج الأمبولات.
Side Effects
-
Safe and well-tolerated when administered by trained hatchery personnel with proper automated equipment.
آمن للغاية عند تطبيقه بواسطة معدات الحقن الآلية في المفرخات.
Images
Documents
-
Download
Poulvac Marek's CVI+HVT Prescribing Information
Leaflet
Active Ingredients
Diseases
No diseases linked.
Related Products
No data available
Information has not been added yet.
Related Products By Active Ingredient
Companies
-
Zoetis
Manufacturer
Alternatives
No alternatives available.